Cytiva & RoosterBio Collaborate to Address Exosome Manufacturing Challenges

Portfolio company Rooster Bio is partnering with Cytiva to solve the challenges of cost and quality by developing improved purification processes.  Exosomes show great promise in gene therapies as a delivery vehicle to carry therapeutic molecules into cells.  This partnership aims to address processing challenges making advanced therapies more accessible.